NBY

Companies
Nyse American
NovaBay Pharmaceuticals, Inc.
Health Care
Price Chart
Overview

About NBY

NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.

Market Cap
$3.1M
Volume
40.1K
Avg. Volume
33.8K
P/E Ratio
-0.60999995
Dividend Yield
212.77%
Employees
41.0

Company Information

Exchange
Nyse American
Sector
Health Care
Industry
Biotechnology
Risk & Correlation Analysis
Market Correlation
0.61
Low Correlation
Volatility
High (1.00)
Relative to market

Macro Factor Sensitivities

Interest Rates
Medium Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
Medium Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions

Premium Forecasts

Get AI-powered price predictions, technical analysis, and market forecasts for NBY.

1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential

Technical Analysis

Based on technical indicators and chart patterns, NBY shows...

AI Sentiment Analysis

Market sentiment analysis indicates...

Key Statistics
Market Cap$3.1M
Volume40.1K
P/E Ratio-0.61
Dividend Yield212.77%
Important Dates
Next Dividend
Next Earnings
April 3, 2025

PortfolioPilot Analysis

Get AI-powered insights on how NBY fits into your investment strategy and portfolio diversification.

Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025